Bradykinesia is a core motor feature of corticobasal syndrome (CBS), characterized by slowness of movement, decreased spontaneous movement, and difficulty initiating voluntary movements. Unlike Parkinson's disease, bradykinesia in CBS demonstrates distinct patterns that reflect the underlying cortical and basal ganglia pathology unique to corticobasal degeneration.
Bradykinesia in CBS results from dysfunction in multiple neural circuits:
- Motor Cortex Involvement: The primary motor cortex (M1) and premotor areas show reduced activation, contributing to decreased movement initiation and execution
- Basal Ganglia Circuitry: Disruption of the direct and indirect pathways in the basal ganglia leads to reduced motor output
- Supplementary Motor Area (SMA): Dysfunction of the SMA, critical for internally-generated movements, contributes to the "movement poverty" seen in CBS
- Subcortical White Matter: Degeneration of frontoparietal white matter tracts disrupts sensorimotor integration
| Mechanism |
Description |
| Dopaminergic dysfunction |
Reduced dopaminergic signaling in the putamen and caudate nucleus |
| Cholinergic deficits |
Loss of cholinergic neurons in the nucleus basalis of Meynert |
| GABAergic dysfunction |
Reduced inhibitory modulation in motor circuits |
| Serotonergic alterations |
Contributing to motor and non-motor features |
- Asymmetric onset: Bradykinesia typically begins on one side, often contralateral to the most affected cerebral hemisphere
- Progressive deterioration: Symptoms worsen over time, eventually becoming bilateral in most cases
- Early disability: Unlike Parkinson's disease, bradykinesia in CBS often leads to early functional impairment
| Feature |
CBS |
Parkinson's Disease |
| Onset |
Asymmetric, cortical signs first |
Usually symmetric |
| Response to levodopa |
Minimal to none |
Significant |
| Progression |
More rapid |
Slower |
| Associated features |
Cortical sensory loss, apraxia |
Resting tremor |
-
Bradykinesia Subscales
- UPDRS Part III items 23-26 (finger taps, hand movements, rapid alternating movements)
- BRAIN Assessment (Bradykinesia Rating in Atypical Parkinsonism)
-
Quantitative Measures
- Finger tapping velocity and amplitude
- Spiral drawing analysis
- Wearable sensor-based kinematics
-
Clinical Rating Scales
- Modified Hoehn and Yahr staging
- Columbia University Rating Scale (CURS)
- Corticobasal Assessment Scale (CBAS)
Bradykinesia in CBS is closely linked to:
Limited Efficacy: Unlike Parkinson's disease, CBS shows minimal response to dopaminergic medications:
- Levodopa/carbidopa: Trial of 500-1000 mg/day; majority show no improvement
- Dopamine agonists: Pramipexole, ropinirole generally ineffective
- MAO-B inhibitors: Selegiline, rasagiline provide minimal benefit
Alternative Approaches:
- Amantadine: May provide modest benefit for some patients
- Modafinil: For fatigue-related movement reduction
-
Physical Therapy
- Graded exercise programs
- Task-specific training
- Constraint-induced movement therapy (modified)
-
Occupational Therapy
- Energy conservation techniques
- Adaptive equipment
- Home modifications
-
Speech Therapy
- LSVT LOUD program adaptations
- Oral motor exercises
- Transcranial magnetic stimulation (TMS): Motor cortex stimulation may improve bradykinesia
- Transcranial direct current stimulation (tDCS): Investigational for motor symptoms
- Deep brain stimulation (DBS): Limited evidence; target selection critical
Bradykinesia severity correlates with:
- Disease progression rate
- Functional disability level
- Cortical atrophy on MRI
- FDG-PET hypometabolism patterns
Current research focuses on:
- Biomarker development: Identifying predictors of bradykinesia progression
- Neuroimaging markers: Using diffusion MRI to assess corticospinal tract integrity
- Neurophysiological studies: TMS and EEG biomarkers of cortical dysfunction
- Armstrong et al., Diagnostic criteria for corticobasal syndrome (2013)
- Boehm et al., Bradykinesia in atypical parkinsonism (2022)
- Scherfler et al., Functional imaging of bradykinesia in CBS (2021)
- Mahapatra et al., Bradykinesia pathophysiology in CBS (2019)
- Rodriguez-Lopez et al., Treatment of motor symptoms in CBS (2020)